ArticleEULAR rheumatology open2026
Burden of fatigue in cryopyrin-associated periodic syndromes.
Article in EULAR rheumatology open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fatigue in Inactive Auto-Inflammatory Diseases and Opportunities for Optimizing Clinical Care: A Single-Center Observational Study.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Fatigue in cryopyrin-associated periodic syndromes (CAPS) often persists despite controlling inflammation. This study explores fatigue burden, its link to disease activity, and factors tied to chronic fatigue in autoinflammatory conditions. Methods: A single-centre study (2007-2024) of children and adults with CAPS analysed demographics, clinical data, inflammation, treatment, disease activity, and fatigue scores. Relationships between these factors and predictors of chronic fatigue were assessed. Results: A total of 108 patients with CAPS were included; 53 were female (49%). Median age at diagnosis was 11 years (range, 0-73); median follow-up duration 7 years (range, 1-18). Muckle-Wells syndrome was the most common phenotype (86%). At the time of diagnosis, hearing loss was present in 30%, aseptic meningitis in 6%. At enrolment, fatigue was the most common symptom, affecting 100 patients (93%), with a median fatigue score of 7 (0-10, visual analogue scale); high disease activity was present in 67%. At the last visit, fatigue remained prevalent, reported in 83 (77%), with a median score of 3 (range, 0-10). Importantly, only 4% of patients had high disease activity, whereas 83% had inactive disease. Factors influencing chronic fatigue in CAPS included age at diagnosis ( Conclusions: Fatigue persists in autoinflammatory diseases despite effective disease control. Further research is needed to identify mechanisms and interventions.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.